Global Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Process (Cell Preservation, Distribution, & Handling, Cell Processing, Process Monitoring & Quality Control), Cell Type, End-User - Forecast 2024-2030- Product Image

Sale

Global Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Process (Cell Preservation, Distribution, & Handling, Cell Processing, Process Monitoring & Quality Control), Cell Type, End-User - Forecast 2024-2030

Report
188 Pages
March 2024
Region: Global
360iResearch™
ID: 4995207

UP TO €848EUR$875USD£726GBP OFF until Dec 31^st 2024

The Cell Therapy Technologies Market size was estimated at USD 19.48 billion in 2023, USD 22.31 billion in 2024, and is expected to grow at a CAGR of 14.63% to reach USD 50.69 billion by 2030.The cell therapy technologies market encompasses the products, services, and techniques employed in the research, development, production, and application of cellular therapies for therapeutic purposes. This includes a wide range of products such as consumables (reagents, enzymes, media), equipment (incubators, centrifuges), and services (cell therapy manufacturing). The field is primarily driven by advancements in regenerative medicine and immunotherapies that focus on repairing or replacing damaged tissue or cells to treat various diseases and disorders. Cell therapy technologies find applications in multiple areas such as oncology, cardiovascular disease treatment, orthopedic treatments, autoimmune disorders management, and inherited genetic disorders correction. The increasing global burden of chronic diseases such cancer, diabetes and cardiovascular disorders has accelerated the demand for innovative therapies. Additionally, favorable funding scenarios from government agencies and private investors have led to increased investments in research activities related to cell therapy development. However, the development and production of cell therapies often require complex procedures, which result in high associated costs, limiting their affordability and accessibility. A dearth of skilled workers may affect the rate at which advancements are made within the industry. Strategic alliances among biopharmaceutical companies and research institutes are rapidly expanding to overcome such challenges. Leveraging artificial intelligence (AI) and machine learning (ML) to optimize processes or identify new targets for cellular therapies and utilization of 3D bioprinting can further expand the scope of the industry.

Regional Insights

The United States and Canada are major contributors to the growth of cell therapy technologies in the Americas. The presence of established biotechnology and pharmaceutical industries, along with numerous research institutions, drives innovation in this sector. The U.S. leads in patents filed for cell therapy innovations, which encourages investments from private and public entities. Furthermore, government initiatives and funding to propel research for oncology and genetic diseases have accelerated the development of gene and cell therapy technologies. In Europe, the European Union (EU) countries lead the market for cell therapy technologies with a strong focus on research and development. Several European biotech firms have made significant progress in clinical trials for advanced therapeutic medicinal products (ATMPs). China, Japan, and India are fast-growing markets for cell therapy technologies within the Asia Pacific region. China has established itself as a major player due to its considerable investment in biotech companies focused on cellular therapies. Chinese regulatory reforms have expedited approval processes for clinical trials, enabling rapid commercialization of cell therapies. Japan leads in regenerative medicine research primarily because of its government's proactive support for the sector.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Therapy Technologies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Therapy Technologies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Technologies Market, highlighting leading vendors and their innovative profiles. These include Anterogen Co., Ltd., Atara Biotherapeutics by FUJIFILM Corporation, Athersys, Inc., Becton, Dickinson and Company, Bluebird Bio, Inc., Bristol-Myers Squibb Company, Cellectis SA, Danaher Corporation, ElevateBio, Gamida Cell, GE Healthcare, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novartis AG, Sartorius AG, STEMCELL Technologies Inc., Takeda Pharmaceutical Company Limited, Tego Science, Terumo Bct, Inc., Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Consumables
- Equipment
  - Cell Processing Equipment
  - Single-Use Equipment
- Software
Process
- Cell Preservation, Distribution, & Handling
- Cell Processing
- Process Monitoring & Quality Control
Cell Type
- Animal Cells
- Human Cells
  - Differentiated Cells
  - Stem Cells
End-User
- Healthcare & Life Science
- Research Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Cell Therapy Technologies Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Therapy Technologies Market?
What are the technology trends and regulatory frameworks in the Cell Therapy Technologies Market?
What is the market share of the leading vendors in the Cell Therapy Technologies Market?
Which modes and strategic moves are suitable for entering the Cell Therapy Technologies Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Cell Therapy Technologies Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of chronic diseases and infections globally
5.1.1.2. Rising GMP certifications for cell therapy production facilities
5.1.1.3. Surge in government initiatives through investments in cell-based research
5.1.2. Restraints
5.1.2.1. High costs associated with cell therapy technologies
5.1.3. Opportunities
5.1.3.1. Ongoing focus on personalized medicine
5.1.3.2. Emergence of iPSCs as an alternative to ESCs in technologies
5.1.4. Challenges
5.1.4.1. Dearth of skilled professionals and stringent regulatory framework
5.2. Market Segmentation Analysis
5.2.1. Product: The advent of big data analytics tools driving the adoption of software tools for cell therapies
5.2.2. Process: Advancements in cell preservation technologies
5.2.3. Cell type: Rising utilization of human cells in cell and gene therapies
5.2.4. End user: Government initiatives to propel investments in research institutes
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Cell Therapy Technologies Market, by Product

6.1. Introduction
6.2. Consumables
6.3. Equipment
6.4.1. Cell Processing Equipment
6.4.2. Single-Use Equipment
6.4. Software

7. Cell Therapy Technologies Market, by Process

7.1. Introduction
7.2. Cell Preservation, Distribution, & Handling
7.3. Cell Processing
7.4. Process Monitoring & Quality Control

8. Cell Therapy Technologies Market, by Cell Type

8.1. Introduction
8.2. Animal Cells
8.3. Human Cells
8.4.1. Differentiated Cells
8.4.2. Stem Cells

9. Cell Therapy Technologies Market, by End-User

9.1. Introduction
9.2. Healthcare & Life Science
9.3. Research Institutes

10. Americas Cell Therapy Technologies Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Cell Therapy Technologies Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Cell Therapy Technologies Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Clade Therapeutics Announces the Acquisition of Gadeta B.V.
13.3.2. New Product Launch & Enhancement
13.3.2.1. NewBiologix Launches with USD 50 million to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
13.3.3. Investment & Funding
13.3.3.1. Startup Cellares adds USD 255 million as investors pour cash into cell therapy production

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Anterogen Co., Ltd.
14.1.2. Atara Biotherapeutics by FUJIFILM Corporation
14.1.3. Athersys, Inc.
14.1.4. Becton, Dickinson and Company
14.1.5. Bluebird Bio, Inc.
14.1.6. Bristol-Myers Squibb Company
14.1.7. Cellectis SA
14.1.8. Danaher Corporation
14.1.9. ElevateBio
14.1.10. Gamida Cell
14.1.11. GE Healthcare
14.1.12. Gilead Sciences, Inc.
14.1.13. JCR Pharmaceuticals Co., Ltd.
14.1.14. Johnson & Johnson Services, Inc.
14.1.15. Lonza Group Ltd.
14.1.16. Merck KGaA
14.1.17. Miltenyi Biotec B.V. & Co. KG
14.1.18. Novartis AG
14.1.19. Sartorius AG
14.1.20. STEMCELL Technologies Inc.
14.1.21. Takeda Pharmaceutical Company Limited
14.1.22. Tego Science
14.1.23. Terumo Bct, Inc.
14.1.24. Thermo Fisher Scientific, Inc.
14.1.25. Vericel Corporation
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. CELL THERAPY TECHNOLOGIES MARKET RESEARCH PROCESS
FIGURE 2. CELL THERAPY TECHNOLOGIES MARKET SIZE, 2022 VS 2030
FIGURE 3. CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. CELL THERAPY TECHNOLOGIES MARKET DYNAMICS
FIGURE 7. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2022 VS 2030 (%)
FIGURE 10. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2022 VS 2030 (%)
FIGURE 12. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 14. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. CELL THERAPY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. CELL THERAPY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. CELL THERAPY TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. CELL THERAPY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 9. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SINGLE-USE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 13. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PRESERVATION, DISTRIBUTION, & HANDLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS MONITORING & QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 17. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 20. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HEALTHCARE & LIFE SCIENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. CELL THERAPY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 46. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 47. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 48. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 49. CANADA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 53. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 54. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 55. MEXICO CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 78. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 79. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 80. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 81. CHINA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 84. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 85. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 86. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 87. INDIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 96. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 97. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 98. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 99. JAPAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 102. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 108. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 114. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 120. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 126. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 132. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 133. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 134. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 135. THAILAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 138. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 149. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 151. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 152. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 153. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 154. DENMARK CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 157. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 158. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 159. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 160. EGYPT CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 163. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 164. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 165. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 166. FINLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 169. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 170. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 172. FRANCE CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 175. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 176. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 177. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 178. GERMANY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 187. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 188. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 189. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 190. ITALY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 199. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 205. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 206. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 207. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 208. NORWAY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 211. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 212. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 213. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 214. POLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 217. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 218. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 219. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 220. QATAR CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 241. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 242. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 243. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 244. SPAIN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 257. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 259. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 260. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 261. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 262. TURKEY CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY HUMAN CELLS, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM CELL THERAPY TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. CELL THERAPY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 276. CELL THERAPY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 277. CELL THERAPY TECHNOLOGIES MARKET LICENSE & PRICING

Companies Mentioned

Anterogen Co., Ltd.
Atara Biotherapeutics by FUJIFILM Corporation
Athersys, Inc.
Becton, Dickinson and Company
Bluebird Bio, Inc.
Bristol-Myers Squibb Company
Cellectis SA
Danaher Corporation
ElevateBio
Gamida Cell
GE Healthcare
Gilead Sciences, Inc.
JCR Pharmaceuticals Co., Ltd.
Johnson & Johnson Services, Inc.
Lonza Group Ltd.
Merck KGaA
Miltenyi Biotec B.V. & Co. KG
Novartis AG
Sartorius AG
STEMCELL Technologies Inc.
Takeda Pharmaceutical Company Limited
Tego Science
Terumo Bct, Inc.
Thermo Fisher Scientific, Inc.
Vericel Corporation

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	188
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 22.31 Billion
Forecasted Market Value ( USD ) by 2030	$ 50.69 Billion
Compound Annual Growth Rate	14.6%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3270EUR$3,374USD£2,801GBP €3633EUR$3,749USD£3,112GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4142EUR$4,274USD£3,548GBP €4602EUR$4,749USD£3,942GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5014EUR$5,174USD£4,295GBP €5571EUR$5,749USD£4,772GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5887EUR$6,074USD£5,042GBP €6541EUR$6,749USD£5,602GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7631EUR$7,874USD£6,536GBP €8479EUR$8,749USD£7,262GBP

Regional Insights

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Cell Therapy Market by Cell Type (Differentiated Cell, Stem Cell), Therapy Type (Allogenic Therapies, Autologous Therapies), Application, End-User - Forecast 2023-2030

Global Cell & Gene Therapy Market by Product (Cell Therapy, Gene Therapy), Delivery Method (Ex Vivo, In Vivo), Application, End-User - Forecast 2024-2030

Global Cell Therapy Human Raw Materials Market Size, Share & Trends Analysis Report, Product (Cell Culture Media, Cell Culture Sera, Cell Culture Supplements), End Use, Region, and Segment Forecasts, 2024-2030

Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report By Product (Media, Sera), By End-use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs), By Region, And Segment Forecasts, 2023 - 2030

Global Cell Therapy Technologies Market by Therapy Type, Therapeutic Area, Region - Forecast up to 2030